. 2016 Jun 30;11(6):e0157371. doi: 10.1371/journal.pone.0157371

Table 7. Urine and plasma MCP-1 levels according to development of complications of cirrhosis during follow up.

COMPLICATIONS OF CIRRHOSIS	Urine MCP-1 (μg/g creat)			Plasma MCP-1 (pg/mL)
COMPLICATIONS OF CIRRHOSIS	YES	NO	p	YES	NO	p
Any complication (n = 100)	0.74	0.47	0.02	252	246	0.4
Any complication (n = 100)	(0.23–1.96)	(0.21–1.05)	0.02	(205–313)	(181–3419)	0.4
Hepatic encephalopath(n = 60)	0.93	0.48	0.01	256	246	0.5
Hepatic encephalopath(n = 60)	(0.32–2.18)	(0.2–1.12)	0.01	(211–313)	(195–332)	0.5
All infections (n = 44)	0.84	0.51	0.07	264	243	0.6
All infections (n = 44)	(0.26–3.15)	(0.21–1.14)	0.07	(195–316)	(196–332)	0.6
SBP (n = 6)	4.28	0.51	<0.001	196	249	0.2
SBP (n = 6)	(3.75–7.42)	(0.21–1.25)	<0.001	(111–317)	(198–331)	0.2
Ascites (n = 34)	0.73	0.53	0.5	224	251	0.6
Ascites (n = 34)	(0.2–2.09)	(0.22–1.26)	0.5	(197–314)	(196–331)	0.6
All AKI (n = 30)	1.43	0.49	0.01	273	246	0.6
All AKI (n = 30)	(0.41–3.72)	(0.21–1.12)	0.01	(190–362)	(198–331)	0.6
HRS (n = 8)	2.8	0.51	0.005	281	246	0.7
HRS (n = 8)	(1.4–10.5)	(0.21–1.24)	0.005	(183–362)	(194–331)	0.7
GI bleeding (n = 13)	1.24	0.54	0.2	200	250	0.07
GI bleeding (n = 13)	(0.21–4.02)	(0.22–1.37)	0.2	(170–275)	(199–331)	0.07

Data are expressed as median (interquartile range). Numbers in brackets after each complication represent the number of patients who developed each complication during the 3-month follow-up period. SBP: spontaneous bacterial peritonitis. HRS: hepatorenal syndrome. GI bleeding: gastrointestinal bleeding.